Digital therapeutics (DTx) companies occupy a uniquely demanding operational space: they must generate clinical evidence, pursue FDA authorization, manage active patient cohorts, and simultaneously build commercial infrastructure — often with funding runways measured in months. According to the Digital Therapeutics Alliance's 2025 Industry Snapshot, there are more than 400 software-based therapeutic products in various stages of regulatory review globally, yet most DTx startups employ fewer than 50 people. The administrative load that falls on small teams is immense. A virtual assistant (VA) with DTx-specific workflow knowledge relieves that load across three critical areas: clinical trial coordination, regulatory submission tracking, and patient communication.
Clinical Trial Coordination
DTx clinical trials involve a dense web of logistics: IRB correspondence, site coordinator communication, participant recruitment pipelines, data collection schedules, and protocol deviation documentation. Clinical and scientific staff should not be spending hours scheduling site calls, chasing missing enrollment paperwork, or formatting adverse event logs. A VA takes on these coordination layers — managing calendars for investigator meetings in Outlook or Google Workspace, maintaining participant enrollment trackers in Airtable or REDCap shadow sheets, and routing completed case report forms to the appropriate clinical team member for review.
For companies using electronic data capture platforms like Medidata Rave or OpenClinica, a VA can handle non-clinical tasks such as user account provisioning, training reminder sequences, and query resolution routing — keeping the trial timeline moving without pulling scientists into administrative queues.
Regulatory Submission Tracking
Navigating FDA's De Novo, 510(k), or Breakthrough Device pathway requires meticulous document management and deadline tracking. A single missed FDA response deadline can reset a review clock by 90 days or more. A VA maintains a live regulatory master calendar — tracking submission dates, FDA information request deadlines, and pre-submission meeting windows — and sends proactive reminders to the regulatory affairs lead using project tools like Smartsheet or Monday.com.
Beyond calendar management, a VA organizes the regulatory document repository: maintaining version-controlled folders for technical files, clinical evaluation reports, software documentation under IEC 62304, and correspondence logs. According to a 2024 Regulatory Affairs Professionals Society (RAPS) survey, administrative document management consumed an average of 11 hours per week for regulatory staff at companies with under 100 employees — time a VA can absorb immediately.
Patient Communication and Retention
Active DTx trials and commercial deployments require consistent patient communication to maintain engagement and protocol adherence. Drop-off rates in digital therapeutic studies average 25–40% across indication areas, per a 2024 JMIR Digital Health analysis — largely due to inadequate touchpoint cadences. A VA manages outbound check-in sequences via SMS, email, or in-app messaging tools like Twilio or SendGrid, sends medication or app-usage reminders based on protocol schedules, and escalates non-responsive participants to the clinical coordinator using a defined escalation matrix.
For commercial DTx products with a patient success function, a VA handles onboarding call scheduling, collects patient-reported outcome (PRO) survey responses, and maintains engagement logs that feed into the company's Salesforce Health Cloud or HubSpot CRM.
Building Operational Leverage in DTx
DTx companies cannot afford to have their clinical scientists doubling as trial administrators or their regulatory leads manually chasing documents. Hire a virtual assistant for your digital therapeutics company who understands the FDA submission cycle, clinical trial logistics, and the patient communication tools your team already uses — and redirect your core team's hours toward the evidence generation that drives authorization and reimbursement.
Sources
- Digital Therapeutics Alliance. (2025). DTx Industry Snapshot. dtxalliance.org
- Regulatory Affairs Professionals Society (RAPS). (2024). Regulatory Staff Time Allocation Survey. raps.org
- JMIR Digital Health. (2024). Dropout Rates in Digital Therapeutic Clinical Studies. jmir.org
- FDA. (2025). De Novo Classification Process for Medical Devices. fda.gov